Leukemia Clinical Trials in North Carolina

Showing 1221-1240 of 1,513 trials

Recruiting African American Fathers/ Sons

NCT02811848

The purpose of this study is to develop and pilot test recruitment methods for a future study of prevention of sexually transmitted infections (STI), including the human immunodeficiency virus (HIV), among Black adolescent boys through sexual health education by their fathers.

Sexually Transmitted DiseasesHIV

Duke University28 participantsStarted May 2016

Greensboro, North Carolina, United States

COMPLETED41 miles

Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia

NCT00437060

This clinical trial is looking at brain function in young patients receiving methotrexate for acute lymphoblastic leukemia. Learning about the long-term effects of methotrexate on brain function may help doctors plan cancer treatment.

Childhood B Acute Lymphoblastic LeukemiaChildhood T Acute Lymphoblastic LeukemiaCognitive Side Effects of Cancer Therapy+4 more

Children's Oncology Group233 participantsStarted Jan 2007

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Downey, California, United States +109 more locations

Recruiting African American Fathers/ Sons

Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia

Leukemia Trials in Other Cities

A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies

Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer

CNDO-109-AANK for AML in First Complete Remission (CR1)

Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye

A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors

PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)

Evaluating Processes of Care & the Outcomes of Children in Hospital (EPOCH)

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

Other Conditions in North Carolina